Institute Receives Support to Establish Excellence in Biopharma
Mar 13 2020 Read 400 Times
The Indian Institute of Technology (IIT Delhi) and Agilent Technologies have recently signed an understanding that will promote biopharmaceutical research. Under the agreement Agilent will contribute funds to support the IIT Delhi incubator in establishing global best practices for identifying and characterising biopharmaceuticals. The research conducted by IIT Delhi examines and reports on the quality of biotherapeutic products for the Indian market.
At the signing, Agilent CEO Mike McMullen spoke about the company’s history of innovation, focus on research and academia and the vision for the future; Prof. V. Ramgopal Rao, the Institute’s Director spoke about its mission and role in promoting collaborations between academia and industry.
We are happy to be associated with Agilent,” said Prof. Anurag S. Rathore (IIT Delhi), Coordinator of the Institutes’s Centre of Excellence for Biopharmaceutical Technology (CBT). “Agilent’s broad range of technologies will further boost our efforts at the Centre of Excellence for Biopharmaceutical Technology. This mutually constructive and productive partnership will hopefully lead to promising results for the entire biotherapeutics ecosystem.”
“We are excited to embark on this initiative with IIT Delhi, an institute with the country’s brightest minds engaged in research and technology,” said Bharat Bhardwaj, country general manager, Agilent India. “Agilent’s relationship with IIT Delhi goes back decades. The new memorandum of understanding that we have signed will further strengthen our relationship and will enhance the ability to do cutting-edge research, which can be used to improve the quality of life for the community at large, through the application of new innovations.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...
View all digital editions
May 31 2020 Houston, TX, USA
May 31 2020 Baltimore, MD, USA
Jun 11 2020 Brussels, Belgium
Jun 20 2020 San Diego, CA, USA
Jun 30 2020 Nuremberg, Germany